Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) EPS (Basic) (2021 - 2026)

HeartSciences (HSCS) has disclosed EPS (Basic) for 5 consecutive years, with -$0.85 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 62.56% year-over-year to -$0.85, compared with a TTM value of -$6.86 through Oct 2025, down 224.73%, and an annual FY2025 reading of -$9.34, up 50.16% over the prior year.
  • EPS (Basic) was -$0.85 for Q4 2025 at HeartSciences, up from -$1.58 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $10.3 in Q1 2024 and bottomed at -$79.36 in Q2 2023.
  • Average EPS (Basic) over 5 years is -$6.22, with a median of -$0.73 recorded in 2022.
  • The sharpest move saw EPS (Basic) plummeted 12909.84% in 2023, then skyrocketed 7457.14% in 2024.
  • Year by year, EPS (Basic) stood at -$0.31 in 2021, then increased by 29.03% to -$0.22 in 2022, then plummeted by 7136.36% to -$15.92 in 2023, then surged by 85.74% to -$2.27 in 2024, then surged by 62.56% to -$0.85 in 2025.
  • Business Quant data shows EPS (Basic) for HSCS at -$0.85 in Q4 2025, -$1.58 in Q3 2025, and -$1.88 in Q2 2025.